Evidence map›Paper›PMID 34268059›Full record

ArticleCureus2021

Echocardiographic Findings in Heart Failure Patients With Methamphetamine Use: A Case-Control Study.

Roopam Jariwal, Vishal Narang, Nadia Raza, Baldeep Mann, Janpreet Bhandohal, Michael Valdez, Theingi Tiffany Win, Fowrooz S Joolhar, Aslan Ghandforoush

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. A Mechanistic Review on Toxicity Effects of Methamphetamine.International journal of medical sciences · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Roopam JariwalInternal Medicine, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.
Vishal NarangInternal Medicine, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.
Nadia RazaInternal Medicine, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.
Baldeep MannInternal Medicine, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.
Janpreet BhandohalInternal Medicine, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.
Michael ValdezInternal Medicine, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.
Theingi Tiffany WinCardiology, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.
Fowrooz S JoolharCardiology, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.
Aslan GhandforoushCardiology, University of California, Los Angeles-Kern Medical Center, Bakersfield, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Methamphetamine use is associated with cardiovascular disease and significant morbidity and mortality. There is only one previous study performed on echocardiographic parameters in patients with methamphetamine cardiomyopathy. Methods We performed a retrospective review of medical records in a county hospital in Southern California with a high population of methamphetamine users. We reviewed medical records and echocardiogram findings in patients seen in our institution from November 2019 to November 2020 who had cardiomyopathy with and without methamphetamine use. We excluded patients who either left the hospital or expired before appropriate assessment. We divided our patient population into a case group (methamphetamine users) and a control group (non-methamphetamine users) to study and compare their echocardiographic parameters. Results Case group included a total of 254 patients and control group included 268 patients. Majority of the patient population were males - 178 (70%) and 180 (67%) in the case and control group respectively. Age was found to be statistically significant with the younger population in the case group (p = 0.0000). Our analysis revealed statistically significant difference in methamphetamine users compared to non-users in regards to left ventricle ejection fraction (33.65% ± 18.02 vs. 41.55% ± 15.61, p=0.0000), left ventricle mass index (122.49 grams/m

Indexed as

diastolic dysfunctionechoheart failure with reduced ejection fractionmethamphetamine induced cardiomyopathytransoesophageal echo

Identifiers

PMID34268059
PMCPMC8262112

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.